Pfizer pneumococcal conjugate formulations
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pfizer pneumococcal conjugate formulations, covering 2024-04-18 to 2024-04-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age [Phase 1]